While many are spending enthusiastically, there is also a movement called the “No Buy” challenge. 2025 is shaping up to be the year of underconsumption or “no buy” trends.
Under the settlement terms, Teva will receive a license to sell a generic version of Auvelity starting March 31, 2039, if pediatric exclusivity is granted.
Equity bulls are struggling at resistance. Last Friday’s news of consumers’ heightened inflation expectations for the next year was used as an opportunity to lighten up at/near resistance.
Wall Street bounced back on Monday, recovering from Friday's robust decline fueled by tariff concerns, as investors remained focused on strong earnings from the fourth-quarter reporting season while awaiting further clarity on trade policie
We are two-for-two for the S&P 500 pushing beyond the 6,100 level resistance, as this week was nearly an exact repeat of the previous. Just as things looked ready to push on, sellers returned.
Futures traders now have their money on one 25-basis-point cut this year, down from two just a couple of weeks ago. Literally no one expects a raise this year.
In this video lesson, I review the current structure of the overall market as it consolidates in this wide and loose price range. I also review the quarterly portfolio and the decision to sell all the names early.
In this week's video, we'll review the latest charts and data help us answer the question, prudent selling based on inflation fears or an overreaction?
The analyst noted that CAN-2409's early data in prostate cancer suggests the potential for a meaningful breakthrough, given the lack of significant advancements in available treatments.
Qualys CEO Sumedh Thakar said the quarterly results demonstrated the rapid pace of innovation and reflected the growing success of newer product initiatives.
Pre-Market Briefing: Feb 6 – Top trade setups using our 4-pillar strategy! $ASTS leads the way, $PBI gears up for earnings, and $PTON & $APPS ride post-earnings momentum.
It's a mixed session on Wall Street, with major indices struggling for direction as investors hold their breath ahead of a key jobs report set for Friday morning. The S&P 500 and the Nasdaq 100 edged up 0.3%, while the Dow Jones slipped 0.1% and small caps held steady.
Wall Street rose on Wednesday, with all major equity indices advancing as investors assessed the latest batch of corporate earnings and drew optimism from positive labor market data.
Markets posted gains sufficient to close breakdown gaps - sufficient to negate these gaps as breakdowns - but leaving indices stuck in broader trading ranges.
U.S. stocks advanced midday Tuesday, demonstrating resilience despite escalating geopolitical tensions and trade uncertainties between the world’s two largest economies.
